Search Menu Globe Arrow Right Close

J. Yang Lab

Personal Statement

As a physician-scientist, I am committed to advancing the clinical management of hepatocellular carcinoma (HCC) through interdisciplinary research and innovation. My work bridges clinical epidemiology, modeling studies and molecular biomarker discovery to enhance early detection, prognostication and treatment response assessment in liver cancer. With support from NIH-funded projects and strong collaborative partnerships, my lab strives to translate leading-edge research into patient-centered strategies that improve diagnosis, optimize treatment pathways and extend survival. By integrating scientific rigor with a focus on real-world impact, I aim to contribute to a future where HCC outcomes are significantly transformed.


Ju Dong Yang, MD

Breakthrough Research

The Yang Lab is dedicated to advancing the early detection and risk stratification of hepatocellular carcinoma (HCC) through the discovery and validation of circulating biomarkers, including circulating tumor cells and extracellular vesicles. By integrating these insights with predictive modeling and molecular profiling, the lab develops precision therapies tailored to individual patients and optimizes treatment responses. Leveraging population-based data, the Yang Lab also addresses global disparities in liver cancer care, guiding more equitable and effective clinical strategies. Our work emphasizes noninvasive, patient-centered approaches that refine surveillance methods, enhance diagnostic accuracy, and ultimately, improve outcomes for individuals affected by liver cancer.

Publications


Learn more about the recent research publications from the J. Yang Lab.

Laboratory Team

Collaborations


The J. Yang Lab collaborates with a wide range of investigators within Cedars-Sinai and in institutions around the world.

Contact the J. Yang Lab

Comprehensive Transplant Center
8900 Beverly Blvd., 252A
Los Angeles, CA 90048